X
TECH icon

Xponance’s Bio-Techne TECH Stock Holding History

Xponance’s Portfolio TECH Stock Details TECH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.2M Buy
17,030
+101
+0.6% +$5.45K 0.01% 726
2026
Q1 		$885K Buy
16,929
+3,851
+29% +$231K 0.01% 788
2025
Q4 		$769K Buy
13,078
+1,155
+10% +$70.2K 0.01% 767
2025
Q3 		$663K Sell
11,923
-1,527
-11% -$81.8K 0.01% 862
2025
Q2 		$692K Sell
13,450
-8,090
-38% -$407K 0.01% 833
2025
Q1 		$1.26M Buy
21,540
+619
+3% +$41.9K 0.01% 618
2024
Q4 		$1.51M Sell
20,921
-650
-3% -$47.7K 0.01% 597
2024
Q3 		$1.72M Buy
21,571
+470
+2% +$35.3K 0.02% 555
2024
Q2 		$1.51M Sell
21,101
-14,075
-40% -$1.04M 0.02% 564
2024
Q1 		$2.48M Buy
35,176
+660
+2% +$47.2K 0.03% 463
2023
Q4 		$2.66M Sell
34,516
-3,008
-8% -$198K 0.03% 406
2023
Q3 		$2.55M Buy
37,524
+1,160
+3% +$91.6K 0.03% 393
2023
Q2 		$2.97M Sell
36,364
-838
-2% -$67.4K 0.04% 363
2023
Q1 		$2.76M Buy
37,202
+1,353
+4% +$104K 0.04% 375
2022
Q4 		$2.97M Buy
35,849
+4,017
+13% +$319K 0.05% 343
2022
Q3 		$2.26M Buy
31,832
+2,092
+7% +$181K 0.04% 362
2022
Q2 		$2.58M Buy
29,740
+3,120
+12% +$292K 0.05% 316
2022
Q1 		$2.88M Buy
26,620
+328
+1% +$33.8K 0.05% 286
2021
Q4 		$3.4M Buy
26,292
+2,628
+11% +$322K 0.05% 271
2021
Q3 		$2.87M Sell
23,664
-10,384
-30% -$1.26M 0.05% 274
2021
Q2 		$3.83M Buy
34,048
+2,840
+9% +$299K 0.07% 225
2021
Q1 		$2.98M Buy
31,208
+396
+1% +$36.1K 0.06% 245
2020
Q4 		$2.45M Sell
30,812
-216
-0.7% -$15.6K 0.05% 279
2020
Q3 		$1.92M Buy
31,028
+2,372
+8% +$154K 0.05% 293
2020
Q2 		$1.89M Buy
+28,656
New +$1.72M 0.05% 275

Other funds holding TECH

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Goldman Sachs
Goldman Sachs New York $1.15T AUM 47.82% 1-Year Est. Return
HI
HBK Investments Dallas, Texas $10.2B AUM 67.73% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return

Xponance's TECH Position: Q2 2026 in Review

Xponance increased its Bio-Techne (TECH) stake by 0.6% in Q2 2026, buying an estimated $5.45K and bringing the position to 17,030 shares worth $1.2M. The position accounts for 0.01% of the portfolio, ranked #726.

Xponance first reported a position in TECH in Q2 2020 and has held it in 25 quarters since. The position peaked at $3.83M in Q2 2021. 593 funds tracked by Wall St. Rank hold TECH as of Q2 2026.

  • Xponance held 17,030 shares of Bio-Techne worth $1.2M as of Q2 2026.
  • Xponance bought 101 Bio-Techne shares in Q2 2026, an estimated $5.45K.
  • Bio-Techne made up 0.01% of Xponance's portfolio in Q2 2026, its #726 holding.
  • Xponance first reported a position in Bio-Techne in Q2 2020 and has held it in 25 quarters since.
  • Xponance's Bio-Techne position peaked at $3.83M in Q2 2021.
  • 593 funds tracked by Wall St. Rank held Bio-Techne as of Q2 2026.

Based on Xponance's 13F filing for Q2 2026, filed 10 Aug 2026.